Movement and health beyond care, MoviS: study protocol for a randomized clinical trial on nutrition and exercise educational programs for breast cancer survivors
Valentina Natalucci,
Carlo Ferri Marini,
Mauro De Santi,
Giosuè Annibalini,
Francesco Lucertini,
Luciana Vallorani,
Andrea Rocco Panico,
Davide Sisti,
Roberta Saltarelli,
Sabrina Donati Zeppa,
Deborah Agostini,
Marco Gervasi,
Giulia Baldelli,
Eugenio Grassi,
Alessandra Nart,
Massimo Rossato,
Vincenzo Biancalana,
Giovanni Piccoli,
Piero Benelli,
Anna Villarini,
Matteo Somaini,
Vincenzo Catalano,
Stefania Guarino,
Alice Pietrelli,
Silvia Monaldi,
Donatella Sarti,
Simone Barocci,
Marco Flori,
Marco Bruno Luigi Rocchi,
Giorgio Brandi,
Vilberto Stocchi,
Rita Emili,
Elena Barbieri
Affiliations
Valentina Natalucci
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Carlo Ferri Marini
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Mauro De Santi
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Giosuè Annibalini
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Francesco Lucertini
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Luciana Vallorani
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Andrea Rocco Panico
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Davide Sisti
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Roberta Saltarelli
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Sabrina Donati Zeppa
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Deborah Agostini
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Marco Gervasi
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Giulia Baldelli
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Eugenio Grassi
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Alessandra Nart
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Massimo Rossato
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Vincenzo Biancalana
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Giovanni Piccoli
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Piero Benelli
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Anna Villarini
Department of Medicine and Surgery, University of Perugia
Matteo Somaini
School of Specialization in Nutrition Science, University of Milano
Vincenzo Catalano
Medical Oncology, Hospital Santa Maria della Misericordia di Urbino
Stefania Guarino
Medical Oncology, Hospital Santa Maria della Misericordia di Urbino
Alice Pietrelli
Medical Oncology, Hospital Santa Maria della Misericordia di Urbino
Silvia Monaldi
Medical Oncology, Hospital Santa Maria della Misericordia di Urbino
Donatella Sarti
Medical Oncology, Hospital Santa Maria della Misericordia di Urbino
Simone Barocci
Clinical Pathology, Hospital Santa Maria della Misericordia di Urbino
Marco Flori
Cardiology, Hospital Santa Maria della Misericordia di Urbino
Marco Bruno Luigi Rocchi
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Giorgio Brandi
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Vilberto Stocchi
Department of Human Sciences for the Promotion of Quality of Life, University San Raffaele
Rita Emili
Medical Oncology, Hospital Santa Maria della Misericordia di Urbino
Elena Barbieri
Department of Biomolecular Sciences, University of Urbino Carlo Bo
Abstract Background Breast cancer (BC) is the most common invasive cancer in women, and exercise can significantly improve the outcomes of BC survivors. MoviS (Movement and Health Beyond Care) is a randomized controlled trial aimed to evaluate the potential health benefits of exercise and proper nutritional habits. This study aims to assess the efficacy of aerobic exercise training in improving quality of life (QoL) and health-related factors in high-risk BC. Methods One hundred seventy-two BC survivor women, aged 30–70 years, non-metastatic, stage 0–III, non-physically active, 6–12 months post-surgery, and post chemo- or radiotherapy, will be recruited in this study. Women will be randomly allocated to the intervention arm (lifestyle recommendations and MoviS Training) or control arm (lifestyle recommendations). The MoviS training consists of 12 weeks of aerobic exercise training (2 days/week of supervised and 1 day/week of unsupervised exercise) with a progressive increase in exercise intensity (40–70% of heart rate reserve) and duration (20–60 min). Both arms will receive counseling on healthy lifestyle habits (nutrition and exercise) based on the World Cancer Research Fund International (WCRF) 2018 guidelines. The primary outcome is the improvement of the QoL. The secondary outcomes are improvement of health-related parameters such as Mediterranean diet adherence, physical activity level, flexibility, muscular fitness, fatigue, cardiorespiratory fitness (estimated maximal oxygen uptake), echocardiographic parameters, heart rate variability (average of the standard deviations of all 5 min normal to normal intervals (ASDNN/5 min) and 24 h very low and low frequency), and metabolic, endocrine, and inflammatory serum biomarkers (glycemia, insulin resistance, progesterone, testosterone, and high-sensitivity C-reactive protein). Discussion This trial aims to evaluate if supervised exercise may improve QoL and health-related factors of BC survivors with a high risk of recurrence. Findings from this project could provide knowledge improvement in the field of exercise oncology through the participation of a multidisciplinary team that will provide a coordinated program of cancer care to improve healthcare quality, improve prognosis, increase survival times and QoL, and reduce the risk of BC recurrence. Trial registration ClinicalTrials.gov NCT04818359 . Retrospectively registered on March 26, 2021